Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 15  •  11:00AM ET
7.30
Dollar change
+0.08
Percentage change
1.04
%
IndexRUT P/E- EPS (ttm)-0.79 Insider Own28.36% Shs Outstand63.04M Perf Week2.60%
Market Cap460.83M Forward P/E- EPS next Y-0.72 Insider Trans-0.28% Shs Float45.26M Perf Month4.96%
Enterprise Value461.63M PEG- EPS next Q-0.28 Inst Own60.99% Short Float7.03% Perf Quarter28.66%
Income-49.18M P/S2.16 EPS this Y10.47% Inst Trans0.63% Short Ratio9.40 Perf Half Y-8.24%
Sales213.75M P/B4.71 EPS next Y10.63% ROA-22.74% Short Interest3.18M Perf YTD-1.95%
Book/sh1.55 P/C6.65 EPS next 5Y9.05% ROE-46.89% 52W High10.79 -32.39% Perf Year41.10%
Cash/sh1.10 P/FCF- EPS past 3/5Y-32.84% -56.40% ROIC-29.90% 52W Low4.54 60.68% Perf 3Y-66.38%
Dividend Est.- EV/EBITDA- Sales past 3/5Y30.40% 39.65% Gross Margin80.12% Volatility6.01% 5.02% Perf 5Y-
Dividend TTM- EV/Sales2.16 EPS Y/Y TTM23.79% Oper. Margin-22.41% ATR (14)0.38 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.51 Sales Y/Y TTM7.67% Profit Margin-23.01% RSI (14)56.83 Recom2.33
Dividend Gr. 3/5Y- - Current Ratio3.52 EPS Q/Q19.17% SMA200.19% Beta0.71 Target Price8.58
Payout- Debt/Eq0.72 Sales Q/Q6.60% SMA5012.50% Rel Volume0.88 Prev Close7.22
Employees477 LT Debt/Eq0.69 EarningsAug 07 AMC SMA200-1.24% Avg Volume338.35K Price7.30
IPOApr 23, 2021 Option/ShortYes / Yes EPS/Sales Surpr.2.91% 0.71% Trades Volume79,891 Change1.04%
Date Action Analyst Rating Change Price Target Change
Feb-04-25Upgrade BTIG Research Neutral → Buy $16
Dec-31-24Initiated Lake Street Buy $14.50
Dec-17-24Resumed JP Morgan Neutral $8
May-16-24Downgrade UBS Buy → Neutral $16 → $6.50
May-08-24Downgrade Truist Buy → Hold $17 → $7
May-08-24Downgrade Stifel Buy → Hold $15 → $6
May-08-24Downgrade Morgan Stanley Overweight → Equal-Weight $15 → $5.50
May-08-24Downgrade JP Morgan Overweight → Neutral $15 → $8
May-08-24Downgrade BTIG Research Buy → Neutral
Sep-29-23Initiated UBS Buy $24
Sep-10-25 07:05AM
Aug-08-25 09:01PM
Aug-07-25 06:05PM
05:03PM
04:05PM
04:01PM Loading…
04:01PM
Aug-05-25 04:05PM
Aug-04-25 05:35PM
Jul-24-25 04:05PM
Jun-05-25 01:00PM
May-30-25 05:45AM
May-13-25 09:55AM
May-09-25 11:55AM
10:15AM
05:45AM
03:43AM Loading…
03:43AM
May-08-25 06:15PM
05:22PM
04:05PM
May-07-25 06:55PM
11:55AM
10:54AM
May-06-25 08:35AM
Apr-25-25 05:45AM
Apr-24-25 04:05PM
Apr-18-25 05:45AM
Apr-07-25 10:08AM
08:00AM
Mar-28-25 02:00PM
Mar-25-25 04:15PM
07:24AM Loading…
Feb-28-25 07:24AM
02:40AM
Feb-27-25 06:25PM
05:28PM
04:05PM
Feb-26-25 08:02AM
Feb-06-25 04:15PM
Feb-04-25 03:17PM
Jan-30-25 08:00AM
Jan-13-25 08:00AM
Jan-02-25 04:15PM
Dec-30-24 08:15AM
Dec-19-24 07:37AM
Dec-16-24 08:30AM
Dec-04-24 04:15PM
Dec-02-24 04:15PM
Nov-18-24 04:46PM
Nov-06-24 10:09AM
02:22AM
Nov-05-24 05:25PM
04:21PM
04:05PM
Nov-04-24 05:29PM
08:00AM
07:12AM
07:00AM
Oct-22-24 04:30PM
Oct-14-24 09:45AM
Oct-09-24 05:08PM
Sep-18-24 10:53AM
Sep-11-24 08:00AM
Aug-22-24 04:15PM
Aug-06-24 07:00PM
05:53PM
04:05PM
Jul-18-24 04:30PM
May-28-24 07:00AM
May-16-24 10:05AM
May-15-24 03:11AM
May-14-24 03:09AM
03:08AM
May-13-24 09:58AM
May-08-24 03:13PM
10:28AM
08:34AM
07:42AM
07:31AM
06:44AM
03:56AM
May-07-24 09:57PM
06:15PM
05:30PM
04:38PM
04:05PM
Apr-24-24 07:00AM
Apr-17-24 07:00AM
Apr-16-24 07:00AM
Apr-09-24 07:00AM
Mar-25-24 07:00AM
Feb-29-24 08:43AM
Feb-27-24 06:35PM
05:28PM
04:40PM
04:05PM
Feb-20-24 10:00AM
Feb-07-24 04:05PM
Feb-02-24 12:00PM
Feb-01-24 07:00AM
Jan-08-24 07:00AM
Dec-19-23 07:00AM
Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scanlan Sean F.Chief Innovation OfficerJul 18 '25Option Exercise0.7233,43724,001383,621Jul 22 05:00 PM
Scanlan Sean F.Chief Innovation OfficerMar 17 '25Option Exercise1.0550,00052,500414,081Mar 19 09:30 PM
Scanlan Sean F.Chief Innovation OfficerMar 17 '25Sale7.9750,000398,460364,081Mar 19 09:30 PM
SEAN SCANLANOfficerMar 17 '25Proposed Sale7.9550,000397,500Mar 17 04:44 PM
Treace John T.Chief Executive OfficerMar 04 '25Buy8.7360,000524,0646,796,190Mar 04 06:30 PM
Treace John T.Chief Executive OfficerSep 16 '24Buy5.3150,000265,6306,523,095Sep 17 05:17 PM